180 related articles for article (PubMed ID: 19302565)
21. [Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)].
Riccardi MT; Chialà A; Lannone F; Grattagliano V; Covelli M; Lapadula G
Reumatismo; 2007; 59(2):135-9. PubMed ID: 17603693
[TBL] [Abstract][Full Text] [Related]
22. Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.
Ichimura Y; Asano Y; Hatano M; Tamaki Z; Takekoshi T; Kogure A; Tomita M; Kawashima T; Miyazaki M; Taniguchi T; Takahashi T; Mitsui H; Sugaya M; Yao A; Kinugawa K; Sato S
Mod Rheumatol; 2011 Oct; 21(5):548-52. PubMed ID: 21547701
[TBL] [Abstract][Full Text] [Related]
23. Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension.
Paul GA; Gibbs JS; Boobis AR; Abbas A; Wilkins MR
Br J Clin Pharmacol; 2005 Jul; 60(1):107-12. PubMed ID: 15963102
[TBL] [Abstract][Full Text] [Related]
24. Bosentan: new indication. Scleroderma and finger ulcers: no tangible efficacy.
Prescrire Int; 2008 Dec; 17(98):238. PubMed ID: 19422150
[TBL] [Abstract][Full Text] [Related]
25. Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval.
Agard C; Carpentier PH; Mouthon L; Clerson P; Gressin V; Bérezné A; Diot E; Jego P; Lok C; Sparsa A; Chatelus E; Van Kien AK; Quéré I; Sibilia J; Hachulla E
Scand J Rheumatol; 2014; 43(5):398-402. PubMed ID: 24720440
[TBL] [Abstract][Full Text] [Related]
26. Severe refractory fingertip ulcerations in a patient with scleroderma: successful treatment with sildenafil.
Colglazier CL; Sutej PG; O'Rourke KS
J Rheumatol; 2005 Dec; 32(12):2440-2. PubMed ID: 16331780
[TBL] [Abstract][Full Text] [Related]
27. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
[TBL] [Abstract][Full Text] [Related]
28. Effects of bosentan on nondigital ulcers in patients with systemic sclerosis.
Taniguchi T; Asano Y; Hatano M; Tamaki Z; Tomita M; Kawashima T; Miyazaki M; Sumida H; Akamata K; Takahashi T; Ichimura Y; Toyama T; Sugita M; Noda S; Yao A; Kinugawa K; Sato S
Br J Dermatol; 2012 Feb; 166(2):417-21. PubMed ID: 21848685
[TBL] [Abstract][Full Text] [Related]
29. Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.
Aversa A; Vitale C; Volterrani M; Fabbri A; Spera G; Fini M; Rosano GM
Diabet Med; 2008 Jan; 25(1):37-44. PubMed ID: 18199130
[TBL] [Abstract][Full Text] [Related]
30. Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 study.
Gruenig E; Michelakis E; Vachiéry JL; Vizza CD; Meyer FJ; Doelberg M; Bach D; Dingemanse J; Galiè N
J Clin Pharmacol; 2009 Nov; 49(11):1343-52. PubMed ID: 19755415
[TBL] [Abstract][Full Text] [Related]
31. Bosentan as a rescue therapy in scleroderma refractory digital ulcers.
Chamaillard M; Heliot-Hosten I; Constans J; Taïeb A
Arch Dermatol; 2007 Jan; 143(1):125-6. PubMed ID: 17224564
[No Abstract] [Full Text] [Related]
32. Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension.
Hoeper MM; Faulenbach C; Golpon H; Winkler J; Welte T; Niedermeyer J
Eur Respir J; 2004 Dec; 24(6):1007-10. PubMed ID: 15572546
[TBL] [Abstract][Full Text] [Related]
33. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
34. [Sildenafil in the treatment of digital ulcers in patients with systemic sclerosis].
Cairoli E; Garra V; Martínez M
Actas Dermosifiliogr; 2009 Nov; 100(9):830-2. PubMed ID: 19889312
[No Abstract] [Full Text] [Related]
35. [Digital ulcers in systemic sclerosis--an interdisciplinary challenge].
Wiesent F; Weinerth J
Med Klin (Munich); 2010 Aug; 105(8):578-81. PubMed ID: 20824416
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
37. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States.
Angalakuditi M; Edgell E; Beardsworth A; Buysman E; Bancroft T
J Med Econ; 2010; 13(3):393-402. PubMed ID: 20608882
[TBL] [Abstract][Full Text] [Related]
38. Digital ulcers: overt vascular disease in systemic sclerosis.
Steen V; Denton CP; Pope JE; Matucci-Cerinic M
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii19-24. PubMed ID: 19487218
[TBL] [Abstract][Full Text] [Related]
39. Digital ulcers and outcomes assessment in scleroderma.
Matucci-Cerinic M; Seibold JR
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v46-7. PubMed ID: 18784143
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
